Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071422
Status:
COMPLETED
Last Update Posted:
2014-07-11
First Post:
2003-10-22
Brief Title:
Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes
Sponsor:
Exsulin Corporation
Organization:
Exsulin Corporation
Organization Data
Organization:
Exsulin Corporation
Class:
INDUSTRY
Study ID:
2003069
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Exsulin Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Muhammad Rehman MD
Old Organization:
Procter and Gamble Pharmaceuticals